5-methoxy-n,n-dimethyltryptamine (5-MeO-DMT) formulations
US12246005B2 · kind B2 · utility
0Cited by
13References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 15, 2024 |
| Grant date | Mar 11, 2025 |
| Priority date | — |
| Expiry date | Mar 15, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M15/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a dry powder formulation of 5-MeO-DMT or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable carriers or excipients. The formulations described herein may be used to treat a disease or condition, such as depression or alcohol use disorder in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.